http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-102020025761-A2
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6040e127692a24856427647cf9831ef5 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-88 |
filingDate | 2020-12-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_66ee7953b651477576cf46178459850a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_63140585961865712017ae7cb7f6e559 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f3c327fcedec2310c13d2096327b5176 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_02593209894a9a44b0042ce9b2020aea |
publicationDate | 2022-06-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | BR-102020025761-A2 |
titleOfInvention | METHOD OF OBTAINING ANTI-INFLAMMATORY GEL COMPOUND CONTAINING SISALANA PERRINE AGAVE EXTRACT (SISAL) ENCAPSULATED IN CHITOSAN AND RESULTING ANTI-INFLAMMATORY GEL |
abstract | It deals with a method of obtaining an anti-inflammatory gel compound containing Agave sisalana Perrine extract (sisal) encapsulated in chitosan that presents active compounds of natural origin associated with nanotechnology, which allows the improvement of the formulation revealing the anti-inflammatory potential of the sisal extract encapsulated in chitosan in vitro and the gel containing the same in vivo, as well as the absence of toxicity of the gel. |
priorityDate | 2020-12-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 139.